Skip to main content
. 2021 Oct 28;13(11):1803. doi: 10.3390/pharmaceutics13111803

Figure 1.

Figure 1

Schematic illustration of various types of cancer nanomedicine formulations—an outline of both approved and in clinical progress (adapted with permission from Reference [7], Accounts of Chemical Research, published by American Chemical Society, 2019).